AKT1 and renal cell carcinoma: We have shown that reduction of 786-O RCC cell viability and induction of apoptosis by luteolin may be attributed to the downregulation of Akt and resultant up-regulation of Ask1, p38, and JNK activities, probably via PP2A activation.